æ–°è¦DNRI「dasotralineã€ã€å°å…ADHD対象ã®è©¦é¨“データを発表ï¼ç±³ã‚µãƒŽãƒ“オン | QLifePro主è¦è©•ä¾¡é …ç›®ã®ADHD RS-IV HVç·ã‚¹ã‚³ã‚¢ã‚’有æ„ã«æ”¹å–„ 大日本ä½å‹è£½è–¬æ ªå¼ä¼šç¤¾ã¯1月16æ—¥ã€ç±³å›½å会社ã§ã‚るサノビオン・ファーマシューティカルズ・インクãŒã€ç±³å›½æ³¨æ„æ¬ å¦‚ãƒ»å¤šå‹•ç—‡å¦ä¼šè°ï¼ˆAPSARD：American Professional Society of ADHD and Related Disorders）㮠2017年年次ç·ä¼šã«ãŠã„ã¦ã€æ³¨æ„æ¬ å¦‚ãƒ»å¤šå‹•ç—‡ï¼ˆADHD）治療剤ã¨ã—ã¦ç±³å›½ã§é–‹ç™ºä¸ã®ã€Œdasotralineã€ï¼ˆä¸€èˆ¬å）ã«ã¤ã„ã¦ã€6～12æ³ã®å°å…ADHD 患者を対象ã¨ã—ãŸãƒ•ã‚§ãƒ¼ã‚º2ï¼3 試験（SEP360-202試験）ã®è©³ç´°ãƒ‡ãƒ¼ã‚¿ã‚’公表ã—ãŸã¨ç™ºè¡¨ã—ãŸã€‚ dasotralineã¯ã€ã‚µãƒŽãƒ“オン社ã®è‡ªç¤¾é–‹ç™ºå“ã§ã€ãƒ‰ãƒ‘ミンãŠã‚ˆã³ãƒŽãƒ«ã‚¨ãƒ”ãƒãƒ•ãƒªãƒ³ã®å†å–ã‚Šè¾¼ã¿ã‚’阻害ã™ã‚‹æ–°è¦ã®DNRI。åŠæ¸›æœŸã¯47～77時間ã¨é•·ãã€24時間ã®æŠ•ä¸Žé–“éš”ã§æŒç¶šçš„ãªæ²»ç™‚効果ãŒå¾—られるã¨æœŸå¾…ã•ã‚Œã¦ã„る。ç¾
FDA approves weight-management drug Contrave
How Relevant is Food Craving to Obesity and Its Treatment? - PMC
ClinicalTrials.gov
Pharmacotherapy of Binge-Eating Disorder: A Review : Journal of Addiction Medicine
Pharmacological management of binge eating disorder: current and emerging treatment options - PMC
Pharmacotherapy of binge-eating disorder: a review - PubMed
Cognitive behavioral therapy guided self-help and orlistat for the treatment of binge eating disorder: a randomized, double-blind, placebo-controlled trial - PubMed
å¤§é˜ªå¤§å¦ å…¨å¦ IT èªè¨¼åŸºç›¤ã‚µãƒ¼ãƒ“ス
{{#tags}}- {{label}}
{{/tags}}